Luke joined Summit in 2017 and focuses primarily on the healthcare & life sciences sector in Europe. His investment and board experience includes RadioOnkologieNetzwerk (acquired by Medipass) and Viroclinics Biosciences.

Prior to Summit, Luke served as Vice President in the Mergers & Acquisitions division of Jefferies.

Luke holds an MA in applied economics, with honors, from the University of St. Andrews.